SEC Form 4 · accession 0001179110-15-006445
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Mar 29, 2015
Accepted (ET)
Apr 20, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 29, 2015 | D | 6,750 | $0.00 | D | 137,862 | D | |
| Common Stock | Apr 16, 2015 | M | 30,000 | $15.12 | A | 167,862 | D | |
| Common Stock | Apr 16, 2015 | M | 10,000 | $15.12 | A | 177,862 | D | |
| Common StockF2 | Apr 16, 2015 | F | 6,215 | $17.08 | D | 171,647 | D | |
| Common StockF3 | Apr 16, 2015 | S | 30,000 | $20.00 | D | 141,647 | D | |
| Common StockF3 | Apr 16, 2015 | S | 10,000 | $20.00 | D | 131,647 | D | |
| Common StockF3,F4 | Apr 17, 2015 | S | 12,910 | $18.05 | D | 118,737 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $15.12 | Apr 16, 2015 | M | 30,000 | A | Aug 19, 2012 | Aug 19, 2018 | Common Stock | 30,000 | 16,452 | D |
| Stock Option (Right to Buy)F3 | $15.12 | Apr 16, 2015 | M | 10,000 | A | Aug 19, 2012 | Aug 19, 2018 | Common Stock | 10,000 | 43,548 | D |
Explanation of responses
- F1Represents a decrease of 6,750 shares of restricted common stock, $0.0001 par value per share, pursuant to the related restricted stock agreement, as amended, between Mr. Leicher and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- F2Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Leicher and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- F3This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2013.
- F4This transaction was executed in multiple trades at prices ranging from $18.00 to $18.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.